-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 P2YIehIg03UIoueF5RQmaOAWSg0MzHpbOnGi9FzTM7TGy2RlQkP5ohPZyRyaXoE8
 Mmtc7ZPEsZ/u1YRrXkQI3Q==

<SEC-DOCUMENT>0000105770-02-000029.txt : 20020814
<SEC-HEADER>0000105770-02-000029.hdr.sgml : 20020814
<ACCEPTANCE-DATETIME>20020814175045
ACCESSION NUMBER:		0000105770-02-000029
CONFORMED SUBMISSION TYPE:	10-Q/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20020630
FILED AS OF DATE:		20020814

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WEST PHARMACEUTICAL SERVICES INC
		CENTRAL INDEX KEY:			0000105770
		STANDARD INDUSTRIAL CLASSIFICATION:	FABRICATED RUBBER PRODUCTS, NEC [3060]
		IRS NUMBER:				231210010
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08036
		FILM NUMBER:		02737423

	BUSINESS ADDRESS:	
		STREET 1:		101 GORDON DR
		STREET 2:		P O BOX 645
		CITY:			LIONVILLE
		STATE:			PA
		ZIP:			19341-0645
		BUSINESS PHONE:		6105942900

	MAIL ADDRESS:	
		STREET 1:		101 GORDON DRIVE
		STREET 2:		PO BOX 645
		CITY:			LIONVILLE
		STATE:			PA
		ZIP:			19341-0645

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WEST CO INC
		DATE OF NAME CHANGE:	19990405
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q/A
<SEQUENCE>1
<FILENAME>file10q202.txt
<DESCRIPTION>AMENDMENT 2
<TEXT>



                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-Q/A


       AMENDMENT No. 2 TO QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934


                  For The Quarterly Period Ended June 30, 2002
                                 --------------

                          Commission File Number 1-8036
                                     ------

                       WEST PHARMACEUTICAL SERVICES, INC.
     ----------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


         Pennsylvania                               23-1210010
     --------------------------------         -----------------------------
     (State or other jurisdiction of              (I.R.S. Employer
      incorporation or organization)            Identification Number)


     101 Gordon Drive, PO Box 645,
           Lionville, PA                             19341-0645
   -----------------------------------             -------------
   Address of principal executive offices)           (Zip Code)



         Registrant's telephone number, including area code 610-594-2900
                      -------------------------------------

                                       N/A

     ----------------------------------------------------------------------
         Former name, former address and former fiscal year, if
                           changed since last report.


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding twelve months, and (2) has been subject to such filing
requirements for the past 90 days. Yes X . No .



                           June 30, 2002 -- 14,462,107
     ----------------------------------------------------------------------
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.

<PAGE>

                                INTRODUCTORY NOTE
                        --------------------------------

West Pharmaceutical Services, Inc. is filing this Amendment No. 2 to Quarterly
Report on Form 10-Q for its fiscal quarter ended June 30, 2002 (the "Form
10-Q"), in order to include information required by Part II, Item 4, which was
inadvertently omitted from the Form 10-Q as originally filed; no other changes
are being made by means of this filing.


                                     PART II


Item. 4. Submission of Matters to a Vote of Security Holders.

(a)  The Company held its annual meeting of shareholders on April 30, 2002.

(c)  Three matters were voted on at the annual meeting: (1) the election of
     three directors in Class III; (2) the approval of an amendment to the
     Company's 1998 Key Employee Incentive Compensation Plan; and (3) the
     ratification of the appointment of PricewaterhouseCoopers LLP as the
     Company's independent accountants for 2002. The results of the voting are
     as follows:


     Proposal #1 - Election of Directors

                                            For               Withheld
                                         ---------            ---------
         Tenley E. Albright              9,609,296            1,634,404
         John W. Conway                  9,611,412            1,632,288
         Donald E. Morel, Jr.            9,609,296            1,634,404

     Proposal # 2 - Amendment  to the 1998 Key Employee  Incentive  Compensation
     Plan

         For                   Against                 Abstained
         ---------             ---------               ---------
         8,133,053             3,082,655               27,989

     Proposal # 3- Ratification of Appointment of Independent Accountants

         For                   Against                 Abstained
         ----------            ---------               ---------
         11,014,887            207,932                 20,878


<PAGE>




                                   SIGNATURES


Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, West Pharmaceutical Services, Inc. has duly caused this report to
be signed on its behalf by the undersigned thereunto duly authorized.



WEST PHARMACEUTICAL SERVICES, INC.
(Registrant)


By  /s/    Joseph E. Abbott
- -----------------------------------------------
Joseph E. Abbott
Vice President and Corporate Controller
(Chief Accounting Officer)


August 14, 2002
- -----------------------------------------------
Date



</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
